TCTC Holdings’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.5M | Sell |
388,238
-300
| -0.1% | -$17.5K | 0.67% | 41 |
|
|
2025
Q4 | $21M | Sell |
388,538
-520
| -0.1% | -$25K | 0.63% | 42 |
|
|
2025
Q3 | $17.5M | Sell |
389,058
-9,719
| -2% | -$454K | 0.52% | 44 |
|
|
2025
Q2 | $18.5M | Sell |
398,777
-8,952
| -2% | -$439K | 0.59% | 42 |
|
|
2025
Q1 | $24.9M | Buy |
407,729
+53
| +0% | +$3.09K | 0.88% | 32 |
|
|
2024
Q4 | $23.1M | Buy |
407,676
+377
| +0.1% | +$21.1K | 0.83% | 31 |
|
|
2024
Q3 | $21.1M | Sell |
407,299
-15,645
| -4% | -$734K | 0.71% | 39 |
|
|
2024
Q2 | $17.6M | Sell |
422,944
-20,600
| -5% | -$922K | 0.6% | 40 |
|
|
2024
Q1 | $24.1M | Buy |
443,544
+3,909
| +0.9% | +$199K | 0.8% | 36 |
|
|
2023
Q4 | $22.6M | Buy |
439,635
+1,116
| +0.3% | +$58.6K | 0.82% | 33 |
|
|
2023
Q3 | $25.5M | Buy |
438,519
+1,092
| +0.2% | +$66.9K | 0.98% | 26 |
|
|
2023
Q2 | $28M | Buy |
437,427
+732
| +0.2% | +$49.1K | 1.12% | 23 |
|
|
2023
Q1 | $30.3M | Buy |
436,695
+5,160
| +1% | +$364K | 1.22% | 18 |
|
|
2022
Q4 | $31M | Buy |
431,535
+2,463
| +0.6% | +$186K | 1.27% | 17 |
|
|
2022
Q3 | $30.5M | Sell |
429,072
-360
| -0.1% | -$26.1K | 1.32% | 16 |
|
|
2022
Q2 | $33.1M | Buy |
429,432
+113
| +0% | +$8.61K | 1.45% | 17 |
|
|
2022
Q1 | $31.4M | Sell |
429,319
-7,229
| -2% | -$485K | 1.29% | 18 |
|
|
2021
Q4 | $27.2M | Buy |
436,548
+3,277
| +0.8% | +$192K | 1.16% | 20 |
|
|
2021
Q3 | $25.6M | Sell |
433,271
-6,160
| -1% | -$406K | 1.18% | 21 |
|
|
2021
Q2 | $29.4M | Buy |
439,431
+14,849
| +3% | +$968K | 1.35% | 19 |
|
|
2021
Q1 | $26.8M | Buy |
424,582
+3,250
| +0.8% | +$202K | 1.27% | 21 |
|
|
2020
Q4 | $26.1M | Buy |
421,332
+5,380
| +1% | +$331K | 1.4% | 20 |
|
|
2020
Q3 | $25.1M | Buy |
415,952
+14,487
| +4% | +$872K | 1.55% | 20 |
|
|
2020
Q2 | $23.6M | Sell |
401,465
-570
| -0.1% | -$34.1K | 1.4% | 18 |
|
|
2020
Q1 | $22.4M | Buy |
402,035
+4,120
| +1% | +$252K | 1.69% | 16 |
|
|
2019
Q4 | $25.5M | Buy |
397,915
+400
| +0.1% | +$22.9K | 1.31% | 16 |
|
|
2019
Q3 | $20.2M | Buy |
397,515
+9,850
| +3% | +$463K | 1.06% | 23 |
|
|
2019
Q2 | $17.6M | Buy |
387,665
+68,550
| +21% | +$3.19M | 0.96% | 28 |
|
|
2019
Q1 | $15.2M | Hold |
319,115
| – | – | 0.82% | 30 |
|
|
2018
Q4 | $16.6M | Buy |
319,115
+400
| +0.1% | +$21.5K | 0.93% | 27 |
|
|
2018
Q3 | $19.8M | Hold |
318,715
| – | – | 0.91% | 25 |
|
|
2018
Q2 | $17.6M | Sell |
318,715
-355
| -0.1% | -$19.2K | 0.85% | 27 |
|
|
2018
Q1 | $20.2M | Buy |
319,070
+400
| +0.1% | +$25.7K | 1.07% | 24 |
|
|
2017
Q4 | $19.5M | Sell |
318,670
-245
| -0.1% | -$15.3K | 1.02% | 25 |
|
|
2017
Q3 | $20.3M | Buy |
318,915
+934
| +0.3% | +$54.5K | 1.25% | 24 |
|
|
2017
Q2 | $17.7M | Hold |
317,981
| – | – | 1.21% | 25 |
|
|
2017
Q1 | $17.3M | Sell |
317,981
-200
| -0.1% | -$11K | 1.06% | 30 |
|
|
2016
Q4 | $18.6M | Sell |
318,181
-3,280
| -1% | -$179K | 1.13% | 26 |
|
|
2016
Q3 | $17.3M | Buy |
321,461
+2,880
| +0.9% | +$185K | 1.27% | 23 |
|
|
2016
Q2 | $23.4M | Buy |
318,581
+216
| +0.1% | +$15.3K | 1.59% | 13 |
|
|
2016
Q1 | $20.3M | Sell |
318,365
-500
| -0.2% | -$31.5K | 1.28% | 19 |
|
|
2015
Q4 | $21.9M | Hold |
318,865
| – | – | 1.32% | 14 |
|
|
2015
Q3 | $18.9M | Buy |
318,865
+9,125
| +3% | +$579K | 1.07% | 19 |
|
|
2015
Q2 | $20.6M | Sell |
309,740
-400
| -0.1% | -$26.4K | 1.18% | 16 |
|
|
2015
Q1 | $20M | Hold |
310,140
| – | – | 1.18% | 18 |
|
|
2014
Q4 | $18.3M | Hold |
310,140
| – | – | 1.11% | 22 |
|
|
2014
Q3 | $15.9M | Sell |
310,140
-40
| -0% | -$2K | 0.92% | 27 |
|
|
2014
Q2 | $15M | Hold |
310,180
| – | – | 0.95% | 24 |
|
|
2014
Q1 | $16.1M | Sell |
310,180
-1,400
| -0.4% | -$74.5K | 0.93% | 23 |
|
|
2013
Q4 | $16.6M | Buy |
311,580
+600
| +0.2% | +$30.6K | 0.95% | 22 |
|
|
2013
Q3 | $14.4M | Hold |
310,980
| – | – | 0.92% | 23 |
|
|
2013
Q2 | $13.9M | Buy |
+310,980
| New | +$13.5M | 0.91% | 23 |
|
Other funds holding BMY
VCM
VPM
TCTC Holdings's BMY Position: Q1 2026 in Review
TCTC Holdings reduced its Bristol-Myers Squibb (BMY) stake by 0.08% in Q1 2026, selling an estimated $17.5K and leaving 388,238 shares worth $23.5M. The position accounts for 0.67% of the portfolio, ranked #41.
TCTC Holdings first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $33.1M in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- TCTC Holdings held 388,238 shares of Bristol-Myers Squibb worth $23.5M as of Q1 2026.
- TCTC Holdings sold 300 Bristol-Myers Squibb shares in Q1 2026, an estimated $17.5K.
- Bristol-Myers Squibb made up 0.67% of TCTC Holdings's portfolio in Q1 2026, its #41 holding.
- TCTC Holdings first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- TCTC Holdings's Bristol-Myers Squibb position peaked at $33.1M in Q2 2022.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on TCTC Holdings's 13F filing for Q1 2026, filed 7 May 2026.